Marc Beer is the CEO of Renovia Incorporation which he founded in August 2016, and was recently appointed as the chairman of LumeNXT. The company’s major goal is to provide the best digital therapy and diagnosis. The company has digitalized devices that give best services to patients especially women who have pelvic floor disorder. Before starting up Renovia, Marc Beer had other business startups and was the chairman of Minerva Neuroscience Incorporated.
The company takes particular interest in treating patients with Central Nervous System disorders. The company, in clinical stage, conducted multiple trials and most investments made in the company were based on innovating researches to come up with therapeutic compounds that would be able to cure some of the mental disorders e.g. insomnia, schizophrenia, and depressive disorder.
Marc Beer has had a solid leadership background in the biopharmaceutical field. This role has helped him put the pharmaceutical companies that he run on a global scale and thus has been able to successfully launch commercial gatherings that has helped him courteously address the issues of these mental and other rare disorders, on a global platform.
Marc Beer, with his proficient leadership skills, has been able to exert authority in administrative posts and has held over the years. With his ability to start up pharmaceutical businesses successfully, Marc Beer has been the founding chairman of many companies which include; Aegerion Pharmaceutical, which mainly focuses on the commercializing and developing of innovations that would be able to help patients with infirming rare conditions and disorders; he was also the Chairman and founder of the board of Good Start Genetics; CEO of ViaCell which was acquired by PerkinElmer in 2007; he was also in the Board of Directors of the Erytech; etc. With his dire interest in the pharmaceutical field and a passion for making a change in that area, Marc Beer became a member of the Mass Life Science Board of the Commonwealth of Massachusetts and was in the Board of Directors that governed emerging companies in the in the Biotechnology Industry Organization.
With over 25 years of leadership experience in the pharmaceutical and biotechnology industry, Marc Beer has been able to make tremendous changes towards development of the companies that he was leading. He has also been involved in various philanthropic activities; he was recently able to raise about 42 million dollars to sponsor emerging pharmaceutical innovations that will focus on the health of women; Renovia Inc. the funds will also be allocated to finance research and the testing of new products. The company will also be able to offer the therapeutic and diagnostic services, with the new biotechnological devices implemented, and Biotechnology be able to treat the pelvic floor disorder in women. This forms the main goal of the Renovia Inc. Learn more: https://renoviainc.com/leadership/